OTAVA Ltd. (aka OTAVAChemicals), an international science-based chemical company, offers more than 250,000 compounds for high-throughput screening including >350 target-focused libraries of compounds (targeted on Protein Kinases, Proteases, GPCRs, Ion Channels, Epigenetic Targets, and others) as well as libraries of Fragments, Lead-like, Drug-like, and CNS compounds. Custom library design is available on customer's request using a proprietary OTAVA Drug Design Approach (ODDA™).

To satisfy the demand for novel screening compounds, OTAVA offers a collection of 4,000,000 Tangible Screening Compounds (with delivery time 4-6 weeks). It is a unique opportunity to enrich customer’s screening collections with compounds which are not offered in any other commercial chemical catalogs.

As a separate line of product, more than 12,000 advanced and diverse Chemical Building Blocks are available for prompt delivery. As an important addition to this in-stock collection, about 5,000,000 new Virtual Chemical Building Blocks could be synthesized and delivered within 6-12 weeks for diversity-oriented syntheses.

A newly founded OTAVA Research Institute, a research arm of OTAVA Ltd., expanded available core competencies to include bioinformatics and development of fluorescent probes for biomedical applications as well the delivery of new technologies to the materials science and plant biotechnology industries.